Patent details
EP1381432 Title:
Basic Information
- Publication number:
- EP1381432
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Expired
- Application number:
- EP019884667
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- Not available
- English Title of Invention:
- French Title of Invention:
- HSA-FREI INTERFERON-BETA FORMULIERUNGEN
- German Title of Invention:
- HSA-FREI INTERFERON-BETA FORMULIERUNGEN
- SPC Number:
-
92060
Dates
- Filing date:
- 26/10/2001
- Grant date:
- 15/02/2012
- EP Publication Date:
- 15/02/2012
- PCT Publication Date:
- Claims Translation Received Date:
- 03/08/2011
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 21/01/2004
- EP B1 Publication Date:
- 15/02/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 26/10/2021
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 06/12/2018
- Name:
- GlaxoSmithKline Biologicals SA
- Address:
- Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)
History of Owners
- From:
- 26/10/2001
- To:
- 06/12/2018
- Name:
- NOVARTIS VACCINES AND DIAGNOSTICS, INC.
- Address:
- HORTON STREET 4560, EMERYVILLE, CALIFORNIA 94608, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 01/02/2012
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- BABUKA SUSAN
- Address:
- United States (US)
2
- Name:
- SHIRLEY BRET A.
- Address:
- United States (US)
3
- Name:
- TELLERS MELANIE
- Address:
- United States (US)
4
- Name:
- CHOE MINNA
- Address:
- United States (US)
Priority
1
- Priority Number:
- 20010330404P
- Priority Date:
- 18/10/2001
- Priority Country:
- United States (US)
2
- Priority Number:
- 20010035397
- Priority Date:
- 25/10/2001
- Priority Country:
- United States (US)
3
- Priority Number:
- 20010282614P
- Priority Date:
- 09/04/2011
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 38/21;
- IPC classification:
- A61K 9/08; A61K 47/12; A61K 47/16;
Publication
Bulletin
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2019/01
- Publication date:
- 09/01/2019
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20180000430A
- Date Registered:
- 06/12/2018
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- MARKS & CLERK LLP
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- GlaxoSmithKline Biologicals SA
- Address:
- Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 18/09/2020
- Last Annual Fee Paid Number:
- 20
- Last Annual Fee Paid Amount:
- 300 Euro
- Payer:
- MASTER DATA CENTER INC (ex Clarivate Analytics)
| Filing date | Document type | Number of pages |
|---|---|---|
| 07/12/2018 | Outgoing Correspondence | 1 |
| 06/12/2018 | Request For Change | 3 |